|Bid||2.6500 x 1300|
|Ask||0.0000 x 800|
|Day's Range||2.6838 - 2.7300|
|52 Week Range||1.9200 - 7.5000|
|Beta (5Y Monthly)||3.33|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 12, 2021 - Aug 16, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
With the business potentially at an important milestone, we thought we'd take a closer look at ThermoGenesis Holdings...
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2021 and provided a corporate strategic update.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / ThermoGenesis Holdings, Inc. (NASDAQ:THMO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.